US Stock MarketDetailed Quotes

MRNA Moderna

Watchlist
  • 39.390
  • -0.170-0.43%
Close Dec 20 16:00 ET
  • 39.640
  • +0.250+0.63%
Post 20:01 ET
15.16BMarket Cap-6.78P/E (TTM)

Moderna Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Moderna Q3 2024 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.25B
1.86B
+615.03M
Beat Est.
-31.90%
+1.69%
+49.32%
EPS
-1.93
0.03
+1.96
Beat Est.
+79.74%
+100.31%
+101.55%
Analyst Rating
Hold

Dec 21, 2024

Moderna Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 140.323M--
--2024/Q4-- / 1.055B--
Nov 7, 20242024/Q31.862B / 1.247B--
Aug 1, 20242024/Q2241.000M / 134.872M--
May 2, 20242024/Q1167.000M / 125.328M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 140.323M--
--2024/Q4-- / 1.055B--
Nov 7, 20242024/Q31.862B / 1.247B--
Aug 1, 20242024/Q2241.000M / 134.872M--
May 2, 20242024/Q1167.000M / 125.328M--

Unlock Free Earnings Estimates

Moderna Earnings Reports

  • Moderna | 10-Q: Q3 2024 Earnings Report

    Nov 8 05:11

  • Moderna | 8-K: Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates

    Nov 7 19:38

  • Moderna | 10-Q: Q2 2024 Earnings Report

    Aug 2 04:10

  • Moderna | 8-K: Moderna Reports Second Quarter 2024 Financial Results and Provides Business Updates

    Aug 1 18:36

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 21, 2024

    Hold

    • Buy

      21.05%

    • Hold

      63.16%

    • Sell

      15.79%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Infectious Disease
    Infectious Disease
    Intraday+0.78%